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Ldb1The Ste20-like kinase SLK plays a pivotal role in cellmigration and focal adhesion turnover and is regulated by the
LIM domain-binding proteins Ldb1 and Ldb2. These adapter proteins have been demonstrated to interact with
LMO4 in the organization of transcriptional complexes. Therefore, we have assessed the ability of LMO4 to also
interact and regulate SLK activity. Our data show that LMO4 can directly bind to SLK and activate its kinase
activity in vitro and in vivo. LMO4 can be co-precipitated with SLK following the induction of cell migration by
scratch wounding and Cre-mediated deletion of LMO4 in conditional LMO4ﬂ/ﬂ ﬁbroblasts inhibits cell migration
and SLK activation. Deletion of LMO4 impairs Ldb1 and SLK recruitment to the leading edge of migrating cells.
Supporting this, Src/Yes/Fyn-deﬁcient cells (SYF) expressing very low levels of LMO4 do not recruit SLK to the
leading edge. Re-expression ofwildtypeMyc–LMO4 in SYF cells, but not amutant version, restores SLK localization
and kinase activity. Overall, our data suggest that activation of SLKbyhaptotactic signals requires its recruitment to
the leading edge by LMO4 in a Src-dependent manner. Furthermore, this establishes a novel cytosolic role for the
transcriptional co-activator LMO4.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
The vast majority of cancer-related deaths are due to the dissemina-
tion of cancer cells to secondary sites. Cell migration is essential to the
metastatic process by which cancer cells have acquired the ability to
invade surrounding tissues and migrate from the primary tumor to
distant sites within the body [1–4]. The process of cell motility involves
the assembly and turnover of focal adhesions regulated by multiple
intracellular signals involving focal adhesion kinase (FAK) and c-Src.
Overexpression, increased activity or activating mutations in c-Src and
FAK have been found in various forms of cancer including breast [5],
ovary [6], head and neck [7], and pancreas [8]. In addition, increased
cell motility has been reported in various forms of cancer [9–12].
The Ste20-like kinase SLK is a 220 kDa serine/threonine kinase
containing three functional domains [13]. The amino terminal kinase
domain shares a high degree of homologywith lymphocyte oriented ki-
nase (LOK), mammalian sterile twenty kinase (MST1), and the Xenopus
polo-like kinase kinase (xPlkk1). The central coiled coil domain containsen-activated protein kinase; IP,
/Fyn-deﬁcient
Institute, Cancer Therapeutics,a Src homology 3 (SH3) binding domain as well as a caspase 3 cleavage
site. The function of the coiled coil region has yet to be elucidated. The
carboxy terminus of SLK consists of anAT1–46homology (ATH) domain
and is also homologous to the carboxy terminus of LOK [13,14]. The ATH
domain confers an autoinhibitory function and interacts directly with
the LIM domain binding transcriptional cofactor proteins Ldb1/CLIM2
and Ldb2/CLIM1/NLI. This interaction negatively regulates the kinase
activity of SLK [15,16]. SLK expressionwas ﬁrst reported to be restricted
to neurogenic and myogenic lineages in the early embryo, followed by
ubiquitous expression in adult tissues and cell lines [13,17]. Recent
work has shown that the lack of functional SLK protein is embryonic
lethal between E12.5 and E14.5 with severe defects in patterning,
organogenesis and placental development [18].
In addition to development, we have found that SLK plays a criti-
cal role in cell adhesion and migration [19–23]. We have shown
that SLK is recruited to the leading edge of migrating cells and co-
localizes with adhesion complex components such as the microtu-
bules, Rac1 and Paxillin. SLK was found to promote focal adhesion
disassembly and cell migration through the phosphorylation of Paxillin
[23]. Activation of SLK kinase activity bymigratory signals is dependent
on the FAK/c–Src/MAPK signaling pathway [21,23]. However, the
molecular mechanisms regulating SLK complex assembly, kinase acti-
vation and its sub-cellular localization during the process of cell migra-
tion remain to be elucidated.
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been associated with poor prognosis and is overexpressed in about
60% of all human breast tumors and in over 60% of HER2-positive
tumors [24,25]. The overexpression of LMO4 in murine mammary
epitheliumwas found to induce hyperplasia and promote cell migration
[24]. LMO4 is also required for ErbB2/HER2/Neu-induced cancer cell
cycle progression through its regulation of cyclin D expression, down-
stream of PI3K [26]. While the majority of the effects of LMO4 may
be caused by its transcriptional co-activator function, there is mounting
evidence that LMO4 possesses cytosolic protein adapter roles in the
context of migration and invasion [27,28]. Supporting this, increased
cytosolic LMO4 staining in metastatic human breast tumor tissue has
been presented [25,29]. Interestingly, its initial discovery was facilitated
by its interactionwith Ldb1 [30,31], a negative regulator of SLK activ-
ity [15]. As LMO4 interacts with Ldb1 and has been shown to also play
a role in cell proliferation and motility, we investigated the possibility
that SLK and LMO4 could interact. In this study, we present evidence
that LMO4 binds directly to the SLK ATH domain and positively regu-
lates SLK activity and cell migration. LMO4 is present at the leading
edge of migrating cells and co-localizes with Ldb1 and adhesion pro-
teins such as vinculin and Paxillin. Deletion of LMO4 impairs SLK
recruitment to the leading edge and inhibits cell migration. Finally,
c-Src deletion or inhibition impairs LMO4 expression and SLK recruit-
ment to the leading edge. Together, these data suggest that LMO4
may contribute to the invasive potential of breast cancers through SLK
and that SLK activity and localization are regulated by a potential
oncogene.
2. Materials and methods
2.1. In vitro binding assays
In vitro binding assays were performed as previously described [15].
Bacteria expressing glutathione transferase (GST) fusion proteins were
collected by centrifugation at 4 °C and resuspended in 500 μL RIPA
lysis buffer including protease inhibitors (50 mM Tris–HCl pH 7.4,
150mMNaCl, 1 mMethylenediaminetetraacetic acid (EDTA), 1% Triton
X-100, 0.5% sodium deoxycholate, 0.1% SDS, 1% Nonidet P-40, 2 mM
DTT, 10 μg/mL leupeptin, 10 μg/mL pepstatin, 10 μg/mL aprotinin,
1 mM phenylmethylsulfonylﬂuoride and 100 μM benzamidine) and
sonicated on ice. Supernatants were cleared by centrifugation;
glutathione-sepharose beads (GE Healthcare, Mississauga, ON, CAN)
were added and rotated for 2 h at 4 °C. Bound GST fusion proteins and
beads were washed three times with 200 mM NETN buffer (20 mM
Tris–HCl pH 8.0, 1 mM EDTA, 200 mM NaCl and 0.5% Nonidet P-40). In
vitro translation products were obtained with the TNT quick-coupled
in vitro transcription translation kit (Promega, Madison, WI) with
35S-methionine (PerkinElmer, Waltham, MA) as per themanufacturer's
instructions and incubatedwith either GST alone or GST-fusion proteins
in 200mMNETN buffer. Complexes were washed 3 timeswith 200mM
NETN, eluted from the beads by boiling in sample buffer and fractionat-
ed by SDS-PAGE. Proteins were visualized using Coomassie Brilliant
Blue (Sigma-Aldrich, St. Louis, MO) staining. Gels were dried and sub-
jected to autoradiography.
2.2. Cell culture, transfections and infections
Mouse embryonic ﬁbroblast (MEF) 3T3, murine mammary carcino-
ma 4T1, human epithelial kidney (HEK) 293, SYF (Src/Fyn/Yes triple
mutant), SYF + c-Src, and primary MEFs were maintained in
Dulbecco's modiﬁed Eagle's medium (DMEM, Invitrogen, Carlsbad,
CA) supplemented with 10% fetal bovine serum (FBS, Invitrogen),
2mML-glutamine (Invitrogen), and penicillin G (200U/mL; Invitrogen)
and streptomycin sulfate (200 μg/mL; Invitrogen) in a humidiﬁed
37 °C incubator at 5% CO2. Primary MEFs from LMO4 ﬂoxed homozy-
gous FVB/N female mice were established as previously described[18]. Immortalization of LMO4 ﬂoxed MEFs was achieved using a
standard 3T3 spontaneous immortalization protocol.
Transient DNA transfections into SYF cells were performed as per
the manufacturer's instructions using Lipofectamine/PLUS reagent
(Invitrogen) with a total of 4 μg of plasmid DNA per each 10 cm plate.
MEF3T3 cells were transfected with 150 nM siRNA (Dharmacon
RNA Technologies, Lafayette, CO) duplex for LMO4 (target sequence:
5′-GCAAGUGAGCUCGUCAUGA-3′) or Dharmacon's non-targeting
duplex as control using the Lipofectamine 2000 (Invitrogen) trans-
fection reagent. Cells were incubated for 48 h at 37 °C and 5% CO2
and assayed for cell migration by a wound closure assay and protein
expression by Western blot analysis.
For Cre-mediated deletion of LMO4, LMO4 ﬂoxed MEFs were plated
at a density of 7.5 × 105 cells on 10 cm plates or 1.875 × 105 cells in
60 mm 6-well dishes in 10% FBS DMEM and incubated overnight at
37 °C and 5% CO2. The cells were then infected with an adenovirus
expressing LacZ as a control (AdLacZ) or Cre recombinase (AdCre;
both a generous gift of Dr. Robin Parks, OHRI, Ottawa, ON) at an MOI
of 20 in serum-free medium for 90 min at 37 °C and 5% CO2. The infec-
tion was followed by the addition of 10% FBS DMEM and the cells were
incubated at 37 °C and 5% CO2 for 48 h prior to analysis via Western
blot, cell migration or immunoﬂuorescence.
2.3. Plasmid constructs
DNA plasmids were constructed using standard molecular clon-
ing techniques. The GST-tagged SLK constructs were generated as
described previously [15]. The murine LMO4 cDNA was PCR ampliﬁed
(N-ter: 5′-ATGGTGAATCCGGGC and C-ter: 5′-TCAGCAGACCTTCTG)
and sub-cloned in frame into the pCAN–Myc expression plasmid. The
point mutations in pCAN–Myc–LMO4 for the quadruple LIM1 domain
mutant (R33G/F34Q/L35Y/Y37Q; Myc–LMO4 QUAD (32)) were gener-
ated according to Stratagene's (Agilent, Santa Clara, CA) ‘QuikChange
XL site-directed mutagenesis kit’ using the Myc-tagged LMO4 cDNA as
the template. Clones were veriﬁed using DNA sequencing. The LMO4
deletion constructs LMO4 ΔLIM1 (aa 1–87) and LMO4 ΔLIM2 (aa 87–
166), were constructed using PCR ampliﬁcation with complimentary
oligonucleotides (LMO4Δ1: 5′-ATGGTGAATCCGGGC and 5′-AGCACC
GCTATTCCC; LMO4Δ2: 5′-TGCAGGGCCTGTGGA and 5′-TCAGCAGACC
TTCTG) and sub-cloned into pCAN–Myc or pGEX 4T1.
2.4. Antibodies and immunoﬂuorescence
The primary antibodies used in this study are as follows: FAK (BD
Transduction Laboratories), FAK pY577 (Invitrogen), Ldb1 (Santa Cruz
Biotechnology, Dallas, TX), Myc (9E10 mouse ascites, Sigma-Aldrich),
Paxillin (BD Transduction Laboratories), Src (Cell Signaling Technology,
Beverly,MA), andα-tubulin (Sigma-Aldrich). The anti-LMO4polyclonal
antibodies were custom made using full length GST–LMO4 as the
immunogen (Medical and Biological Laboratories Co. Ltd., Nagoya,
Japan). The anti-LMO4 monoclonal antibody has been previously
described (Sum EY et al. [24], J Histochem Cytochem). The anti-SLK
polyclonal has been previously described [20].
For immunoﬂuorescence studies, cells were seeded in 10% FBS
DMEM on coverslips coated with ﬁbronectin (10 μg/mL, Invitrogen)
and incubated overnight at 37 °C and 5% CO2 or until conﬂuent for
migration studies. For coverslips intended for migration studies, a
micropipette tip was used to create two parallel wounds in untreated
or inhibitor-treated (1 h pre-treatment prior to wounding with 10 μM
PP2 or PP3; EMD-Millipore [Calbiochem], Darmstadt, Germany) cell
monolayers. Growth media were replaced with fresh 10% FBS DMEM,
including any small molecule inhibitors required for the experiment,
and cells were incubated for 1 h at 37 °C and 5% CO2 prior to ﬁxation
with 4% paraformaldehyde. Following permeabilization with 0.3%
Triton X-100 in STO-PBS, cells werewashed and blockedwith 5% bovine
serum albumin (BSA, Sigma-Aldrich) in PBS for 20 min. Cells were
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was added directly to coverslips, which were then incubated for
1 h at room temperature. Primary antibodies were detected using
anti-mouse, anti-goat or anti-rabbit secondary antibodies, conjugat-
ed to either ﬂuorescein isothiocyanate (Alexa Fluor 488, Sigma-
Aldrich) or tetramethyl rhodamine isothiocyanate (Alexa Fluor 594,
Sigma-Aldrich). Cellular nuclei were stained with 4, 6-diamidino-2-
phenylindole (DAPI, Invitrogen). Slides were visualized with a Zeiss
Axioscope 100 epiﬂuorescence microscope equipped with the appro-
priate ﬁlters and photographed using Axiovision software (Carl Zeiss
Canada Ltd., Toronto, ON, CAN). Cells that showed reactivity at the lead-
ing edge of the wound were scored as a positive event. Counts were
obtained from ﬁve images along the wound edge for two coverslips
per transfection, infection or treatment. Statistical analyses are shown
for three independent experiments. The error bars in all graphs repre-
sent the mean ± the standard error of the mean. P-values were deter-
mined using the two-tailed paired sample Student's t-test.
2.5. Migration assays
Wound closure assays were performed by seeding MEF3T3 cells
in 10% FBS DMEM onto ﬁbronectin-coated (10 μg/mL, Invitrogen)
60 mm 6-well dishes following transfections with the desired siRNAs
as described above, and incubating the cells at 37 °C and 5% CO2 for
48 h and/or to conﬂuency. Micropipette tips were then used to create
two parallel wounds in the cell monolayer and the growth medium
was replaced with fresh 10% FBS DMEM. The wounds were then
incubated at 37 °C and 5% CO2. Phase contrast photomicrographs of
predetermined and constant locations along the wound edge were
obtained at 0 and 6 h post-wounding using a Nikon Eclipse TE2000-U
microscope. Fluorescence images ofwoundswere obtained as described
above. Boyden chambermigration assays were performed as previously
described [23].
Scratch wound induced migration analysis was performed as
described previously [21]. In brief, conﬂuent MEF3T3 cell monolayers
were serum-starved overnight in 0.25% FBS DMEM and scratched with
a micropipette tip until 50% of the cells were removed from the mono-
layer. The cellswere then incubated and collected at various time points
up to 2 h post-wounding for biochemical analysis.
2.6. Western blot analysis, immunoprecipitation and in vitro kinase assays
Cell pellets were collected and lysed for protein analysis using a
RIPA buffer including protease inhibitors as described above. Lysates
were sonicated on ice and cleared by centrifugation at 14,000 rpm
at 4 °C. Protein concentrations in the cleared supernatants were quanti-
ﬁed using the Bradford protein assay reagent (Bio-Rad, Hercules, CA).
For Western blot analysis, equal amounts of protein (20–50 μg) were
electrophoresed on 4–20% gradient pre-cast SDS-PAGE gels (Bio-Rad)
and transferred onto polyvinylidene diﬂuoride (PVDF) membranes.
Membranes were probed overnight at 4 °C with the speciﬁed primary
antibodies in 5% BSA in TBST (50 mM Tris–HCl pH 7.4, 150 mM NaCl,
0.1% Tween-20). Primary antibodies were detected using the appro-
priate anti-mouse, anti-goat or anti-rabbit horseradish peroxidase-
conjugated secondary antibody (Bio-Rad). Proteins were detected by
chemiluminescence (PerkinElmer) and exposed to X-ray ﬁlm.
For immunoprecipitations, equal amounts of protein (200–500 μg)
were incubatedwith the required primary antibody and 20 μL of protein
A/G bead slurry (GE HealthCare) for 2 h at 4 °C. The beads and bound
proteins are washed four times with 200 mM NETN containing
0.25mMNaVO3. Protein complexeswere eluted from the beads by boil-
ing in sample buffer, electrophoresed on polyacrylamide gels and trans-
ferred onto PVDF membranes as described above. Membranes were
probed with the appropriate antibodies as described above to detect
proteins. For SLK in vitro kinase assays, the immunoprecipitates were
also washed once in kinase buffer (0.25 mM NaVO3, 20 mM Tris–HClpH 7.4, 1 mM NaF, 10 mM β-glycerophosphate, 1 mM DTT, and
15 mM MgCl2) and autophosphorylation reactions were initiated by
the addition of 20 μL kinase buffer containing 1 μL [32P]γ-ATP (5 μCi/
μL) to each sample followed by a 30minute incubation at 30 °C. The re-
actions were terminated and protein complexes eluted from the beads
by the addition of a sample buffer and boiling. Proteins were electro-
phoresed and transferred to PVDF membranes as above. Membranes
were exposed to X-ray ﬁlms and target proteins were visualized by
probing the membranes with the appropriate antibodies as described
above. Densitometrywas performedusing the ImageJ software (Nation-
al Institutes of Health, Bethesda, MD) to quantify images obtained from
autoradiography.
3. Results
3.1. LMO4 interacts directly with SLK and is required for cell migration
Wehave previously shown that SLKplays a central role in cellmigra-
tion [16,20–22] and heregulin-inducedmotility and invasion [19]. Inter-
estingly, we have shown that the transcriptional co-activators Ldb1
and Ldb2 (Ldbs) play novel functions in the cytosol by regulating SLK
activity and cell migration [15]. The Ldbs have been observed to interact
with LMO4 [30,32–34]. This binding is critical for the organization of
transcriptional complexes regulatingmultiple developmental programs
[35–41]. Together, these ﬁndings suggest that the LMO4/Ldb complex
might regulate numerous cellular processes. As we have shown that
SLK activity is regulated by the Ldbs [15], we have tested whether
LMO4 is also part of the SLK complex.
As shown in Fig. 1A, immunoprecipitation of SLK from exponentially
growing MEF3T3 ﬁbroblasts resulted in the co-precipitation of LMO4
suggesting that LMO4 associates with the SLK complex in vivo. The co-
precipitated LMO4 signal was markedly decreased upon Cre-mediated
deletion of LMO4 in conditional ﬁbroblasts, demonstrating the speciﬁc-
ity of the anti-LMO4 signal (Fig. 1B). Although LMO4 is mostly nuclear,
a small fraction was found to co-localize with SLK at the leading edge
of migrating cells following scratch wounding (Fig. 1C–E). As for SLK,
LMO4 also co-localized with Paxillin in membrane rufﬂes but not in
focal adhesion complexes [21] as well as with Ldb1 at the leading
edge of migrating cells [15] (Suppl. Fig. 1). The SLK and LMO4 patterns
were lost upon SLK knockdown or LMO4 deletion (Suppl. Fig. 2).
Together these data suggest that LMO4 interacts with the SLK/Ldb
complex in vivo.
To assess whether LMO4 interacts directly with SLK, we performed
in vitro binding assays using recombinant proteins. Direct GST-pull
downs using in vitro translated SLK or LMO4 shows that the interaction
is mediated by the c-terminal ATH domain of SLK and the ﬁrst LIM
region of LMO4 (Suppl. Fig. 3). Although not tested here, it is likely
that in the context of the SLK complex and the Ldbs, the binding could
be enhanced [32,42–44].
Following scratch wounding, SLK is activated and localizes to the
leading edge of migrating cells within 60 min [15,21,23]. As LMO4 can
directly associate with SLK, we investigated whether this interaction
is affected by scratch wounding. Conﬂuent ﬁbroblast monolayers were
wounded [45] and SLK immunoprecipitates were surveyed for LMO4.
Scratch wounding resulted in a 2-fold upregulation in SLK activity
(Fig. 2A & Suppl. Fig. 5A). This was also accompanied with an increase
in co-precipitated LMO4. The migration-dependent SLK activation
and complex formation were also conﬁrmed in the murine mammary
carcinoma cell line 4T1 (Suppl. Fig. 6). Complex formation peaked at
60 min when kinase activity was maximal. These results suggest that
LMO4 is recruited to SLK during cell migration. Although total SLK levels
are similar in ﬁbroblasts (not shown), the peak SLK kinase activity is
higher in 4T1 cells, suggesting potential differences in cancer cells.
As LMO4 deletion results in SLK downregulation in exponentially
growing cells (Suppl. Fig. 6B), we tested whether the loss of LMO4
would also affect SLK activation following scratch wounding. Although
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Fig. 1. LMO4 associates with SLK in vivo and colocalizes with the kinase at the leading edge of migrating cells. (A) Endogenous SLK was immunoprecipitated (IP) from sub-conﬂuent
MEF3T3 cells and blotted back for LMO4 (polyclonal antibody; pAb). LMO4was found to co-precipitatewith SLK. A non-speciﬁc signal (*) is also observed. The co-precipitated LMO4 signal
was abolished following deletion of LMO4 (B). MEF3T3 cells were seeded on ﬁbronectin-coated coverslips, grown to conﬂuency and scratchwounded. Scratched cells were ﬁxed with 4%
PFA 60min post-wounding and immunostained. Individual coverslipswere stained for LMO4 (monoclonal antibody) (C) and SLK (D). Cells showed co-localization of SLK and LMO4 at the
leading edge (arrowheads) (E). Scale bar 10 μ.
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Cre-mediated deletion of LMO4 resulted in a failure to activate SLK
upon scratchwounding (Fig. 2B & Suppl. Fig. 5B). More importantly, de-
letion of LMO4 led to a further decrease in SLK activity after wounding,
suggesting that LMO4 is required to activate and maintain SLK activity
during cell migration. Supporting a role for LMO4 in SLK activation,
addition of exogenous GST–LMO4 to SLK immunoprecipitates resulted
in a ~2-fold increase in SLK activity when normalized to total SLK levels
(Fig. 2C & Suppl. Fig. 5C).
LMO4 has been shown to interact directly with Ldb1 [43]. In addi-
tion, we have shown that the Ldb1/2 co-factors play a role in cell migra-
tion and the regulation of SLK kinase activity [15]. Therefore, we
investigated the effect of LMO4 deletion on cell motility. To investigate
the role of LMO4 on cell migration, both siRNA (Fig. 3A–B) and Cre-
mediated LMO4 deletion (Fig. 3C–D) were used. As shown in Fig. 3,
both Cre recombinase treatment of conditional LMO4 ﬁbroblasts
or siRNA knockdown leads to a marked decrease in LMO4 expression
combinedwith a signiﬁcant delay inwound closure (50–60% reduction)
and transwell migration (not shown) . Overall, these results suggest
that LMO4 is required for SLK activity and efﬁcient cell migration.
3.2. LMO4 is required to recruit the Ldb1–SLK complex at the leading edge
The failure to activate SLK in LMO4-deﬁcient cells suggests that
its recruitment to the complex is required to induce kinase activity.
Alternatively, LMO4 is critical for the localization of SLK at the leading
edgewhere it can be activated. To investigate this, we performed immu-
noﬂuorescence for SLK on wounded monolayers 60 min following
Cre-mediated deletion of LMO4. As we have previously shown [21,23],
SLKwas found to be recruited to the leading edge of migrating cells fol-
lowing monolayer wounding (Fig. 4A and G). Surprisingly, deletion ofLMO4 resulted in a marked reduction (~6-fold) in the proportion
of cells that displayed SLK staining to the leading edge following scratch
wounding (Fig. 4D and G), suggesting that LMO4 is necessary for the
recruitment of SLK to the front of migrating cells.
Our previous ﬁndings showed that the Ldb1/2 co-activators directly
interact with SLK to regulate its kinase activity and cell migration
[15]. Interestingly, staining for Ldb1 also revealed a 5-fold decrease in
the proportion of cells recruiting it to the leading edge (Fig. 4E and H),
suggesting that LMO4 deletion also alters the recruitment of SLK-
associated proteins. Although wildtype cells showed focal adhesion
and lamellipodial staining of Paxillin, Cre-mediated deletion of
LMO4 resulted in enlarged focal adhesions with an absence of Paxillin-
positive lamellipodiae, suggesting that focal adhesion turnover is im-
paired (Fig. 4C and F). This has also been observed in SLK-deﬁcient
cells [21–23]. Together, these data suggest that LMO4 is required to
recruit the SLK complex to the leading edge of migrating cells. Further-
more, the LMO4-mediated localization of SLK at the leading edge
appears to be critical for its activation during cell migration.
As LMO4deletion also impairs the recruitment of Ldb1 to the leading
edge, we tested whether the SLK–Ldb1 association was affected by
the loss of LMO4. LMO4-ﬂoxed ﬁbroblasts growing exponentially were
infected with AdCre and subjected to IP-westerns. Deletion of LMO4
did not affect the ability of Ldb1 to associate with the SLK complex
in vivo (Fig. 5A and B). However, deletion of Ldb1 in conditional ﬁbro-
blasts abrogates the ability of LMO4 to interact with SLK in vivo,
suggesting that Ldb1 is critical for the LMO4–SLK interaction.
3.3. LMO4 expression and SLK recruitment requires c-Src activity
We have previously observed a defect in SLK leading edge recruit-
ment in cells lacking the Src-family kinases Src, Yes and Fyn (SYF; [21,
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Fig. 2. LMO4 is required for SLK activation following scratch wounding. (A) Conﬂuent monolayers of MEF 3T3 cells were scratch wounded and collected at 0 (−) and 60 (+)
minutes post-wounding. Endogenous SLK protein was immunoprecipitated (IP) and subjected to an in vitro kinase assay. Scratch wounding resulted in a ~2-fold increase in
kinase activity (see Suppl. Fig. 5) as well as higher amounts of co-precipitated LMO4. Blot back for SLK showed equivalent amounts of immunoprecipitated kinase. Whole cell
lysates (WCL) immunoblotted for SLK and LMO4 showed no change in expression following wounding. (B) LMO4-ﬂoxed MEF cells were infected with AdCre and allowed to
grow to conﬂuency at 37 °C and 5% CO2. Cells were scratch wounded and endogenous SLK was immunoprecipitated and subjected to in vitro kinase assays. LMO4 deletion
resulted in a failure to activate SLK following scratchwounding, indicating that LMO4 expression is required for SLK activation in migrating cells. Knockdown of LMO4 expression
validated byWestern blot analysis of the cell lysates (WCL).(C) HA-SLKwas immunoprecipitated from transfected HEK293 cells (12CA5) and subjected to an in vitro kinase assay
in the presence or absence of recombinant GST–LMO4. Densitometry showed a 2-fold increase in SLK activity in the presence of GST–LMO4. Whole cell lysates (WCL) were
analyzed by Western blot for the presence of transfected HA-tagged protein or tubulin as a loading control. Kinase assays were performed in triplicates and one representative
is shown.
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wounding [21]. Therefore, we investigated whether SYF cells were
also deﬁcient in LMO4 redistribution to the leading edge of migrating
cells. Surprisingly, Western blot analysis revealed that SYF cells
expressed markedly reduced levels of LMO4 (Fig. 6A). Re-expression
of c-Src restored LMO4 expression back to levels comparable to those
detected in MEF3T3 ﬁbroblasts (Fig. 6B), suggesting that Src activity is
required to maintain LMO4 expression. Although the LMO4 exposure
times are 10 times longer than SLK, either protein could not be detected
at the leading edge of migrating SYF cells (Fig. 6C and F) or MEF3T3
treated with the Src inhibitor PP2 (Fig. 7A–B). These data suggest that,
in SYF cells, the low levels of LMO4 are not sufﬁcient to drive SLK re-
cruitment to the leading edge. To test this, epitope-tagged Myc–LMO4
was expressed in SYF cells and the SLK and LMO4 distributions were
assessed by immunoﬂuorescence. Stainingwith LMO4or anti-Myc anti-
bodies (Suppl. Fig. 7) revealed that Myc–LMO4 was expressed in SYF
cells and localized to the leading edge in addition to the nucleus
(Fig. 6D). Similarly, c-Src re-expression restored LMO4 levels and
leading edge staining (Fig. 6B and E). This suggests that LMO4 ex-
pression requires Src-family kinases but that its recruitment to the
leading edge is Src-independent. Supporting a role for LMO4 in the
localization of the SLK complex at the leading edge, expression of
Myc–LMO4 in SYF cells restored SLK staining at the front of migrating
cells (Fig. 6G), similar to the pattern seen in cells re-expressing c-Src
(Fig. 6E and H). These data strongly suggest that Src-family kinases
are required for LMO4 expression which in turn recruits the SLK
complex to the leading edge of migrating cells. To determine whether
Src family kinase activity is required for SLK localization, conﬂuentMEF3T3 cells were treated with the Src inhibitor PP2 or its control
PP3, scratched wounded and allowed to migrate for 60 min in the
presence of the inhibitor or control. Immunostaining showed that SLK
was detected at the leading edge of cells treated with PP3 (Fig. 7A)
but not in cells treatedwith the Src inhibitor PP2 (Fig. 7B). Immunopre-
cipitation of SLK in PP2 treated cells showed a marked reduction in
SLK-associated LMO4 (Fig. 7C). Whole cell lysate analysis showed that
short-term inhibition of Src activity was not sufﬁcient to decrease
LMO4 protein expression but resulted in a block of FAK tyrosine phos-
phorylation at a c-Src site (Y577). In addition, PP2 treatment also
inhibited MEF3T3 cell migration (Suppl. Fig. 7C). These results indicate
that SLK recruitment at the leading edge and cell migration are depen-
dent upon LMO4 association with SLK, which is regulated by Src
activity.
To better deﬁne the domains that mediate the recruitment of the
SLK complex, LMO4 mutants and truncations were expressed in SYF
cells and the proportion of cells recruiting SLK to the leading edge was
quantitated from random ﬁelds along the wound edge. Critical LMO4
residues involved in the Ldb1–LMO4 interface have been identiﬁed
[32]. Expression of a quadruple LMO4 point mutant (Quad) that lacks
critical LIM1domain residues for interactionwith the Ldb1–LDBdomain
[32] could not rescue SLK recruitment (Fig. 8B and E). However, expres-
sion of amutant that lacked the second LIMdomain (LMO4Δ2) showing
interaction with both SLK and Ldb1/2 (Suppl. Fig. 3&4 and (32)) re-
sulted in SLK re-localization to the leading edge (Fig. 8C and E). Expres-
sion of a Quad-LMO4Δ2 mutant binding to SLK but not to Ldb1 could
not rescue SLK relocalization. These results suggest that SLK recruit-
ment is dependent on its direct interactionwith LMO4 but also requires
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Fig. 5. Ldb1 deletion impairs SLK–LMO4 association in vivo. (A) LMO4 was deleted
from LMO4-ﬂoxed ﬁbroblasts and SLK immunoprecipitates were probed for Ldb1.
(B) Whole cell lysates (WCL) were probed for proteins in the SLK complex. LMO4
expression was undetectable. (C) Ldb1 was deleted from Ldb1 conditional ﬁbroblasts
and SLK immunoprecipitates were assessed for LMO4. (D) Probing of whole cell lysate
(WCL) showed marked Ldb1 knockdown but no change in SLK or LMO4.
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Our previous work has established that SLK is required for focal ad-
hesion turnover and cell migration [19,21–23] . We have also shown
that the Ldb1/2 transcriptional co-activator can negatively regulate
SLK to control cell motility [15]. Here we report a novel cytosolic func-
tion for the transcriptional co-factor LMO4, known to interact withLMO4
C-src
Tubulin
A
LMO4
Tubulin
B
LMO4
SLK
C
F
50
27
50
Fig. 6. c-Src regulates LMO4 protein levels, SLK subcellular localization inmigrating cells and th
were immunoblotted to evaluate LMO4 protein levels. The SYF cell line was found to express ve
(B). (C–G) SYF cells were seeded on ﬁbronectin coated coverslips, transfected with Myc–LMO
60 min prior to staining for LMO4 (C–E) or SLK (F–H). No SLK or LMO4 staining could be det
that of SLK or Myc–LMO4 (600 ms vs 60 ms). SLK leading edge staining was restored upon e
cells on ﬁbronectin-coated coverslips show SLK and LMO4 staining in membrane rufﬂes and leLdb1/2. As for Ldb1/2, we show that LMO4 can also interact directly
with SLK. Similarly, it can be localized to the leading edge of migrating
cells with Paxillin, SLK and Ldb1. Deletion of LMO4 in conditional
LMO4ﬂ/ﬂ MEFs results in an inhibition of cell migration and a failure
to recruit and activate SLK at the leading edge ofmigrating cells. Surpris-
ingly, deletion of Ldb1 results in a loss of interaction between LMO4 and
SLK. Interestingly, SYF cells express very low levels of LMO4 and cannot
recruit SLK to the leading edge. This can be rescued by re-expression
of wildtype LMO4 or a mutant that binds both SLK and Ldb1 but not
to SLK alone. Combined with the observation that PP2 impairs the
SLK–LMO4 interaction and SLK recruitment to the leading edge, our
data suggest that SLK activation and recruitment to the leading edge
of migrating cells is dependent on its interaction with LMO4 in a
Src-dependent manner. Furthermore, this binding is required for efﬁ-
cient cell migration.
LIM domain containing proteins represent a large family encompas-
sing cytosolic adapters and transcriptional regulators (extensively
reviewed in [47]). The LIM domain is essentially a protein interaction
motif and is involved in diverse biological functions. Surprisingly,
a number of LIMproteins have been shown to regulate both cytoskeletal
remodeling and transcription. LIM domain proteins such as Paxillin,
Zyxin, PINCH and FHLs have been shown to play a role in focal adhesion
turnover and cytosolic signaling [47]. They have also been shown
to shuttle into the nucleus, suggesting a dual role in cytoskeletal remod-
eling and transcription. Interestingly, several LIM domain containing
proteins have been implicated in cancer progression or invasion.Nuclear
localization of Paxillin is postulated to play a role in prostate cancer
through interaction with the androgen receptor [48,49]. Similarly,
Zyxin-related proteins appear to play a role in tumor cell invasion [50].
Furthermore, the SLK-binding proteins Ldb1/2 have also been shown
to play a role in tumorigenesis and to regulate cell migration [15,30,
33,36]. Together, these observations highlight novel and important
roles for LIM-domain adapter proteins.
Up to now LMO4 had been characterized as a neuronal signaling
adapter [27,28,51] with a role in synaptic regulation and axon guidance.
The regulation of cell migration is a novel cytosolic function for the
LMO4 protein. Interestingly, a large number of signaling molecules
implicated in neuronal activity and guidance also play regulatory roles
in cell migration [52–54]. Mechanistically, the regulation of SLK appearsMyc-LMO4
SYF SYF + SYF + c-src
D E
G H
e LMO4–SLK interaction. (A) Src/Yes/Fyn-deﬁcient (SYF) cells and SYF+ c-Src populations
ry low levels of LMO4 protein that were restored upon c-Src or Myc–LMO4 re-expression
4 and allowed to grow to conﬂuency. The monolayers were scratched and incubated for
ected at the leading edge of SYF cells. Capture time for LMO4 was 10 times longer than
xpression of exogenous LMO4 or c-Src (arrowheads in D and G). (E and H) SYF + c-Src
ading edge. Scale bar, 20 μ.
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Fig. 7. SLK recruitment and interaction with LMO4 is Src-dependent. Conﬂuent MEF3T3 monolayers were pre-treated with the Src inhibitor PP2 (A) or control PP3 (B) (1 h, 10 μM) and
scratch wounded and immunostained for SLK. PP2-treated cells did not show positive SLK staining at the leading edge of cells in contrast to control cultures (arrowheads). (C) Scratch
wounded MEF3T3 monolayers pre-treated with the Src inhibitor PP2 or control PP3 (1 h, 10 μM) were allowed to recover for 60 min in the presence of inhibitors. Endogenous SLK
was immunoprecipitated (SLK IP) and blotted back for LMO4. Whole cell lysate (WCL) was probed with anti-FAK pY577 to conﬁrm Src inhibition in the PP2-treated cells. No change in
LMO4 expression was observed.
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phosphorylation [55,56] as well as interaction with adapter proteins
[15]. Although its activation by migratory signals requires FAK [19,21],
its recruitment to the leading edge is dependent on Src-family kinase
activity (Fig. 6 and 7 and [21]). Surprisingly, the levels of LMO4 are
markedly reduced in SYF cells. However, expression of Myc–LMO4 in
SYF cells results in its recruitment at the leading edge. These data sug-
gest that its leading edge localization does not require Src activity
(see Fig. 6 and Suppl. Fig. 7) but rather its expression is Src-dependent.
Inhibition of c-Src by PP2 treatment results in a loss of LMO4–SLK
interaction (Fig. 7) and an absence of SLK at the leading edge. This
suggests that the activity of SLK can be modulated by both the levels
of LMO4 and Src-dependent SLK re-localization. Surprisingly, although
PP2 inhibits SLK recruitment in cells expressing LMO4, its over-Fig. 8. SLK recruitment and activation require the LMO4 LIM1 domain. (A–D) SYF cells were see
with empty vector or LMO4 constructs (Quad, LMO4Δ2 or QuadLMO4Δ2). Conﬂuent coverslipsw
SLK protein was found to be absent from the leading edge in the vector — (A), Quad — (B), an
LMO4Δ2-expressing cells (C). (E) Quantiﬁcation of positively stained cells was obtained by c
view and statistical signiﬁcance was calculated using the Student's t-test (*p b 0.01). (F) Wes
non-speciﬁc (NS) anti-Myc reactive bandwas consistently observed in all samples. (G) SLK kin
ious LMO4 constructs and scratch wounding (see Suppl. Fig.5D). Kinase assays were performeexpression in Src-deﬁcient cells is sufﬁcient to rescue SLK recruitment
(Fig. 7G). One possibility is that over-expression of LMO4 in the absence
of c-Src can induce its binding to Ldb1, resulting in SLK recruitment.
Alternatively, the localization of LMO4 at the leading edge is Src-
independent but SLK recruitment to LMO4 requires the activation of
cell migration. Interestingly, deletion of LMO4 also impairs the recruit-
ment of Ldb1 at the leading edge but not its association with SLK.
However, deletion of Ldb1 markedly reduces the association of LMO4
with SLK suggesting that Ldb1 is required for LMO4 binding and recruit-
ment of the SLK complex at the leading edge.
Thus far SLK we have not been able to show tyrosine phosphoryla-
tion on SLK, suggesting that c-Src is unlikely to phosphorylate SLK
directly to regulate its sub-cellular localization. Most likely, the recruit-
ment of SLK to the leading edge of migrating cells involves intermediateded on ﬁbronectin-coated coverslips and following overnight incubation, were transfected
ere scratchwounded and incubated for 60min at 37 °Cprior toﬁxing and staining for SLK.
d QuadLMO4Δ2-expressing (D) SYF cells. Positive leading edge staining was observed in
ounting the number of SLK-positive leading edge cells at the wound face in 10 ﬁelds of
tern blot analysis showing expression of the LMO4 constructs in transfected SYF cells. A
ase assays showing the relative fold-increase in kinase activity upon expression of the var-
d in triplicates and one representative is shown.
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of upstream SLK regulators and additional binding proteins will further
our understanding of its molecular regulation.
Overexpression of LMO4 in mammary epithelium has been shown
to induce mammary hyperplasia and promote cell migration [24]. In
addition, overexpression of LMO4 has been observed in about 60%
of all human breast tumors and in over 60% of HER2-positive tumors.
This overexpression has also been correlated with high grade tumors
and poor clinical outcome [24,25]. Importantly, increased cytosolic
LMO4 staining in metastatic human breast tumor tissue has been pre-
sented [24,25,29]. Supporting this, deletion of LMO4 in ﬁbroblasts
results in decreased SLK activity and reduced cell migration (Fig. 3).
The observation that SLK activity is also enhanced by activated HER2/
ErbB2 [19] raises the possibility that LMO4 over-expression in those
tumors might be mediating the increase in SLK activity.
LMO4 has been shown to be required for ErbB2/HER2/Neu-induced
cell cycle progression through G2/M by regulating cyclin D expression,
downstream of PI3K [26,29]. Interestingly, we have also shown that
SLK is required for cell cycle progression through G2/M [57]. Expression
of dominant negative SLK results in a delay in G2/M progression and a
failure to downregulate cyclin A with normal levels of cyclin D. This
suggests that SLK and LMO4might regulate cell cycle progression differ-
ently. Alternatively, the transcriptional role of LMO4 is independent of
its cytosolic functions that involve SLK regulation. Our data show that
SLK also displays a perinuclear pattern of staining. Although SLK–
LMO4 co-localization is also observed at the leading edge, the interac-
tion could also take place in the perinuclear space. One possibility
is that the perinuclear interaction may be more relevant for G2/M
transit and cell cycle progression. Further studies will be required to
dissect its speciﬁc functions in the different sub-cellular compartments.
5. Conclusion
Overall, wehave shown that SLK redistribution andactivation during
cell migration is dependent on Src activity and interaction with LMO4.
This association requires c-Src activity and is critical for cell migration.
Whether LMO4 deletion or overexpression of LMO4 in breast cancer
leads to the modulation of SLK activity and altered cancer progression
remains to be investigated. Nevertheless, themodulation of SLK activity
by a potential oncogene makes it an attractive therapeutic target. Our
understanding of the complexmechanisms regulating SLK activity awaits
further studies.
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